News

MCG study was accepted at the Asia Pacific Society of Cardiology(APSC) Congress 2020

A MCG study was accepted at the Asia Pacific Society of Cardiology(APSC) Congress 2020.
This congress is co-held with Japan Society of Cardiology (JSC) in 12-14 March, 2020 in Kyoto, Japan.
The details of presentation is as follows.

Session Title: ACS/AMI (clinical/diagnosis) 3
Date: Friday, March 13, 2020 AM
Abstract Title: Feasibility study of artificial intelligence(AI) based Multifunction CardioGram(MCG) technology and its potential to help reduce cardiac death.

For details of congress, please visit the following site.
http://www.congre.co.jp/apsc2020/

MCG was exhibited in the 60th Japan Ningen Dock Society

In 25-26 July, 2019, MCG was exhibited at the conference of  60th Japan Ningen Dock Society held in Okayama prefecture.　This  is the largest conference for health check up in Japan, attending more than 4,000 doctors and co-medicals.
MCG was co-exhibited with the wearable electrode “HITOE”, which was future electrodes without stress of adhesive gel and intertangling of leading codes.

MCG was presented by Dr.Amano at the ECG study group in Saitama

There was a lecture and presentation on MCG at the 15th Kita-Saitama ECG Study group held on May 27 in Fukaya, Saitama.
At the lecture, Dr. Tetsuya Amano(MD, PhD) , a professor of Aichi Medical University, gave a lecture on non-invasive examination and MCG for cardiovascular disease.
In the lecture, he explained it is important to evaluate the functional significant stenosis of the entire heart using SYNTAX score and FFR, etc when identifying cardiovascular disease.
Also he talked about expectations for MCG as a non-invasive alternative to invasive tests such as CTA and CAG, which are not recommended to the patients without symptoms.

In addition, Dr. Noboru Kujirai of Kagohara Hospital introduced cases of MCG. He explained a case about the patient with significantly higher MCG scores after PCI, and a case where restenosis was found in-stent with moderate MCG scores.

This lecture was very valuable for all audience to deepen their understanding about MCG.

MCG study is presented in ACC(American College of Cardiology) Asia

A  MCG study was accepted and presented at the Conference of ACC (American College of Cardiology ) Asia in December 2018.

The study was conducted in Myanmar. 30 patients (MCG score ≥ 4 ) were enrolled and compared the MCG results with the CAG results (75%-100% stenosis were positive).

The Average MCG score of CAG positive group was 7.0 and negative group was 5.4 (p<0.01). MCG cut off was 6, and it shows sensitivity:76.5%, specificity:69.2%, PPV76.5%, NPV69.2%, accuracy:73.3%(P<0.05).

The study concluded MCG showed high sensitivity and specificity, and MCG is effective as a noninvasive device for detection of severe IHD in Myanmar where catheterization facilities and doctors are very limited.

Please refer to the abstract from here.

Premier Heart exhibited MCG in the 59th Annual scientific meeting of Japan Society of Ningen Dock.

The 59th Annual scientific meeting of Japan Society of Ningen Dock was held in August 30th and 31st in Niigata, Japan.

Thousands of medical specialists gathered and many studies were presented during the meeting.

Premier Heart exhibited MCG at the meeting and we thank many doctors and co-medical specialists who visited and listened to our presentation about MCG services.

Japan society of Ningen Dock is the largest organization for health checkup centers in Japan.

More than 4,000 doctors, nurses, and people related to medical entity will gather the meeting and have presentations and discussions about the health check up and preventive medicine.

Premier Heart exhibits MCG in the 59th Annual scientific meeting of Japan Society of Ningen Dock.

The 59th Annual scientific meeting of Japan Society of Ningen Dock will be held in August 30th and 31st in Niigata, Japan.
Premier Heart exhibits MCG at the meeting as an exhibitor.

Japan society of Ningen Dock is the largest organization for health checkup centers in Japan.
More than 4,000 doctors, nurses, and people related to medical entity will gather the meeting and have presentations and discussions about the health check up and preventive medicine.

If you have chance to come to Japan, please visit the meeting.
We are looking forward to seeing you there.

Attended ASEAN Medical Devices CEO meeting in Tokyo

Premier Heart International(PHI) attended the ASEAN CEO Business Matching Meeting for Medical Device held  in Tokyo on 15-16 of March,2018.

PHI met a lot of good distributors from Indonesia, Malaysia, Thailand, Vietnam and Taiwan, and talked about sales, marketing and other business opportunities each other. This was really fruitful networking for everyone.

PHI will take advantage of these valuable opportunities for expanding MCG business into Asia.